bf/NASDAQ:KMDA_icon.jpeg

NASDAQ:KMDA

Kamada Pharmaceuticals

  • Stock

6.57

+1.55%

−0.73

USD last updated 15/08 02:20:07

Last Close

7.30

14/08 22:06

Market Cap

339.10M

Beta: 0.24

Volume Today

30.55K

Avg: 21.91K

PE Ratio

42.09

PFCF: 184.28

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytopenic purpura and suppression of r...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -0.10.10.20.30.42017-11-132019-11-132021-11-222023-05-242024-11-11

    Revenue (Estimate*)

    50M100M150M2017-11-132019-11-132021-11-222023-05-242024-11-11

    *Estimate based on analyst consensus